Insilico Medicine
PrivateLast Round
IPO
Dec 30, 2025
Est. Valuation
$1.72B
Total Funding Raised
$854.01M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Insilico Medicine is a biotechnology company that develops an advanced AI platform and innovative drugs aimed at providing transformative solutions for cancer, fibrosis, immune disorders, central nervous system diseases, and age-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Insilico Medicine Comparables
Compare Insilico Medicine with similar companies based on industry and business-model similarity.
Insilico Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Dec 30, 2025 | ||||
| Series E | Jun 16, 2025 | ||||
| Series E | Mar 13, 2025 | ||||
| Series E | Jan 7, 2025 | ||||
| Debt | Nov 5, 2024 | ||||
Series D Extension | Aug 11, 2022 |
Key People
Founding team and executive leadership
Insilico Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series C, Series D Extension |
| AIBasis Fund | Series C |
| Credit Suisse Asset Management | ipo |
| Temasek | ipo |
| Baidu Ventures | Series C, Series B |
| Lake Bleu Capital | Series C |
| Winter Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Unified AI framework integrates TargetPro and TargetBench for improved drug development.
- Mar 24, 2026
Partnered with ASKA Pharmaceutical Co., Ltd. for drug discovery.
Insilico Medicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Insilico Medicine's valuation, stock price, and market status.